Novel genetic variations of the p53R2 gene in patients with colorectal adenoma and controls

AIM: p53-Inducible ribonucleotide reductase small subunit 2 (p53R2) encodes a 351-amino-acid peptide, which catalyzes conversion of ribonucleoside diphosphates to the corresponding deoxyribonucleotides required for DNA replication and repair. A recent study reported that a point mutation (G/T) in th...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 11; no. 33; pp. 5169 - 5173
Main Authors Deng, Zong-Lin, Xie, Da-Wen, Bostick, Roberd M, Miao, Xi-Jiang, Gong, You-Ling, Zhang, Jin-Hui, Wargovich, Michael J
Format Journal Article
LanguageEnglish
Published United States Tumor Center,West China Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China%Department of Pathology,University of South Carolina School of Medicine and South Carolina Cancer Center,Columbia SC 29203,United States 07.09.2005
Department of Epidemiology and Biostatistics,University of South Carolina School of Public Health and South Carolina Cancer Center,Columbia SC 29203,United States%Department of Epidemiology,Rollins School of Public Health,Emory University,Atlanta,GA 30322,United States%Department of Computer Science and Engineering,University of South Carolina,Columbia SC 29201,United States%Department of Epidemiology and Biostatistics,University of South Carolina School of Public Health and South Carolina Cancer Center,Columbia SC 29203,United States
Baishideng Publishing Group Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AIM: p53-Inducible ribonucleotide reductase small subunit 2 (p53R2) encodes a 351-amino-acid peptide, which catalyzes conversion of ribonucleoside diphosphates to the corresponding deoxyribonucleotides required for DNA replication and repair. A recent study reported that a point mutation (G/T) in the p53 binding sequence in a colon cancer cell line completely impaired p53R2 protein activity. METHODS: We screened the p53R2 gene coding regions and a regulatory region which contains a p53 binding sequence in 100 patients with colorectal adenoma and 100 control subjects using PCR, cold SSCP, and direct DNA sequencing. RESULTS: Although we did not identify genetic variation in all nine exons, four regulatory-region variants were found, of which three were single nucleotide polymorphisms (SNPs) (nt 1 789 C/G, nt 1 928 A/G, 1 933 T/C), and one was 20 bp insertion which replaced a ATTTT between nt 1 831 and 1 835. Additionally, we determined the frequency of these p53R2 variants in a recently concluded case-control study of incident sporadic colorectal adenomas (163 cases and 210 controls). CONCLUSION: Although more detailed functional characterizations of these polymorphisms remain to be undertaken, these polymorphic sites may be useful for identifying alleles associated with mis-splicing, additional transcript factors and, more generally, in cancer-susceptibility association studies.
Bibliography:R735.3
p53R2, SSCP
14-1219/R
Genetic polymorphism
PCR-RFLP
Colorectal neoplasia
Genetic polymorphism; Colorectal neoplasia;p53R2, SSCP; PCR-RFLP
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence to: Dr. Da-Wen Xie, University of South Carolina, 14 Richland Medical Park, Suite 500, Columbia, SC 29203, United States. dawen.xie@palmettohealth.org
Telephone: +1-803-434-3707 Fax: +1-803-434-3795
Author contributions: All authors contributed equally to the work.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v11.i33.5169